Startseite Trends in pediatric obesity management, a survey from the Pediatric Endocrine Society Obesity Committee
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Trends in pediatric obesity management, a survey from the Pediatric Endocrine Society Obesity Committee

  • Ashley H. Shoemaker ORCID logo , Stephanie T. Chung , Amy Fleischman EMAIL logo und on behalf of the Pediatric Endocrine Society Obesity Special Interest Group
Veröffentlicht/Copyright: 18. Februar 2020

Abstract

Background

In the United States, 18.5% of children are obese. Dietary and lifestyle modifications are key, but often ineffective. There are limited approved pediatric pharmacotherapies. The objective of this study was to evaluate current treatment practices for pediatric obesity among members of the Pediatric Endocrine Society (PES, n = 1300) and the Pediatric Obesity Weight Evaluation Registry (POWER, n = 42) consortium.

Methods

A 10-question online survey on treatment of children with obesity in clinical practice was conducted.

Results

The response rates were 19% for PES and 20% for POWER members. The majority were female (65%) and board certified in pediatric endocrinology (81%). Most practitioners saw 5–10 patients with obesity/week and 19% prescribed weight-loss medications. POWER participants were more likely to prescribe weight-loss medications than PES participants (46% vs. 18%, p =  0.02). Metformin was the most commonly prescribed medication. Response to medication was poor. Use of dietary non-pharmacological treatment options was uncommon. Over half of the respondents (56%) referred patients for bariatric surgery and 53% had local access to pediatric bariatric surgery.

Conclusions

Metformin was the most common drug prescribed among respondents, but successful weight-loss responses were uncommon. Among practitioners who are using pharmacological interventions, therapeutic strategies vary widely. Targeted research in pharmacologic and surgical treatment for pediatric obesity is urgently needed.

Acknowledgments

We would like to acknowledge all of the survey participants and the leadership of the Pediatric Endocrine Society and the POWER consortium for their support. AS, SC and AF, along with the PES Obesity committee members, conceived and carried out the survey. AS, SC and AT analyzed data and prepared the manuscript. All authors were involved in writing the paper and had final approval of the submitted and published versions.

  1. Author contributions: All authors designed the study, analyzed the data, contributed to the manuscript and approved the final manuscript submission.

  2. Research Funding: Dr. Shoemaker receives research funding from Soleno Therapeutics, Rhythm Pharmaceuticals, AstraZeneca, GLWL Research Inc., Vivus Inc. and Boehringer-Ingelheim. Dr. Chung is supported by the Intramural Program at the NIH, Bethesda, MD. Dr. Fleischman receives research funding from Soleno Therapeutics, Levo Therapeutics and Millendo Therapeutics.

  3. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

  4. Statement of ethics: This study was approved by the Vanderbilt University Medical Center IRB.

References

1. Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity among adults and youth: United States, 2015–2016. NCHS Data Brief 2017;288:1–8.Suche in Google Scholar

2. Serdula MK, Ivery D, Coates RJ, Freedman DS, Williamson DF, et al. Do obese children become obese adults? A review of the literature. Prev Med 1993;22:167–77.10.1006/pmed.1993.1014Suche in Google Scholar PubMed

3. Chung ST, Onuzuruike AU, Magge SN. Cardiometabolic risk in obese children. Ann N Y Acad Sci 2018;1411:166–83.10.1111/nyas.13602Suche in Google Scholar PubMed PubMed Central

4. McGill Jr HC, McMahan CA, Herderick EE, Zieske AW, Malcom GT, et al. Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation 2002;105:2712–8.10.1161/01.CIR.0000018121.67607.CESuche in Google Scholar PubMed

5. Imperatore G, Boyle JP, Thompson TJ, Case D, Dabelea D, et al. Projections of type 1 and type 2 diabetes burden in the U.S. population aged <20 years through 2050: dynamic modeling of incidence, mortality, and population growth. Diabetes Care 2012;35:2515–20.10.2337/dc12-0669Suche in Google Scholar PubMed PubMed Central

6. Barnett TA, Kelly AS, Young DR, Perry CK, Pratt CA, et al. Sedentary behaviors in today’s youth: approaches to the prevention and management of childhood obesity: a scientific statement from the American Heart Association. Circulation 2018;138: e142–e59.10.1161/CIR.0000000000000591Suche in Google Scholar PubMed

7. Styne DM, Arslanian SA, Connor EL, Farooqi IS, Murad MH, et al. Pediatric obesity-assessment, treatment, and prevention: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2017;102:709–57.10.1210/jc.2016-2573Suche in Google Scholar PubMed PubMed Central

8. Bray GA, Heisel WE, Afshin A, Jensen MD, Dietz WH, et al. The science of obesity management: an endocrine society scientific statement. Endocr Rev 2018;39:79–132.10.1210/er.2017-00253Suche in Google Scholar PubMed PubMed Central

9. Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, et al. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract 2016;22 (Suppl 3):1–203.10.4158/EP161365.GLSuche in Google Scholar PubMed

10. Bolling CF, Armstrong SC, Reichard KW, Michalsky MP, Section On Obesity SOS. Metabolic and bariatric surgery for pediatric patients with severe obesity. Pediatrics 2019;144:e20193224.10.1542/peds.2019-3224Suche in Google Scholar PubMed

11. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, et al. Research electronic data capture (REDCap) – a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42:377–81.10.1016/j.jbi.2008.08.010Suche in Google Scholar PubMed PubMed Central

12. Guttmann-Bauman I, Thornton P, Adhikari S, Reifschneider K, Wood MA, et al. Pediatric endocrine society survey of diabetes practices in the United States: what is the current state? Pediatric Diabetes 2018;19:859–65.10.1111/pedi.12677Suche in Google Scholar PubMed

13. Lentferink YE, Knibbe CAJ, van der Vorst MM. Efficacy of metformin treatment with respect to weight reduction in children and adults with obesity: a systematic review. Drugs 2018;78:1887–901.10.1007/s40265-018-1025-0Suche in Google Scholar PubMed

14. O’Connor EA, Evans CV, Burda BU, Walsh ES, Eder M, et al. Screening for obesity and intervention for weight management in children and adolescents: evidence report and systematic review for the US Preventive Services Task Force. JAMA 2017;317:2427–44.10.1001/jama.2017.0332Suche in Google Scholar PubMed

15. McDuffie JR, Calis KA, Uwaifo GI, Sebring NG, Fallon EM, et al. Efficacy of orlistat as an adjunct to behavioral treatment in overweight African American and Caucasian adolescents with obesity-related co-morbid conditions. J Pediatr Endocrinol Metab 2004;17:307–19.10.1515/JPEM.2004.17.3.307Suche in Google Scholar

16. Mastrandrea LD, Witten L, Carlsson Petri KC, Hale PM, Hedman HK, et al. Liraglutide effects in a paediatric (7-11 y) population with obesity: a randomized, double-blind, placebo-controlled, short-term trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics. Pediatr Obes 2019;14:e12495.10.1111/ijpo.12495Suche in Google Scholar PubMed PubMed Central

17. Inge TH, Courcoulas AP, Jenkins TM, Michalsky MP, Brandt ML, et al. Five-year outcomes of gastric bypass in adolescents as compared with adults. N Engl J Med 2019;380:2136–45.10.1056/NEJMoa1813909Suche in Google Scholar PubMed PubMed Central

18. Roebroek YG, Talib A, Muris JW, van Dielen FM, Bouvy ND, et al. Hurdles to take for adequate treatment of morbidly obese children and adolescents: attitudes of general practitioners towards conservative and surgical treatment of paediatric morbid obesity. World J Surg 2019;43:1173–81.10.1007/s00268-018-4874-5Suche in Google Scholar PubMed


Supplementary Material

The online version of this article offers supplementary material (https://doi.org/10.1515/jpem-2019-0546).


Received: 2019-11-25
Accepted: 2020-01-27
Published Online: 2020-02-18
Published in Print: 2020-04-28

©2020 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Review
  3. Prevalence of obesity and overweight in Iranian students: a systematic review and meta-analysis
  4. Original Articles
  5. Trends in pediatric obesity management, a survey from the Pediatric Endocrine Society Obesity Committee
  6. Utility of MR proton density fat fraction and its correlation with ultrasonography and biochemical markers in nonalcoholic fatty liver disease in overweight adolescents
  7. Vitamin D status and its relation to insulin resistance in a Mexican pediatric population
  8. Elevated serum uric acid, hyperuricaemia and dietary patterns among adolescents in mainland China
  9. Is there a relationship between the dietary inflammatory index and metabolic syndrome among adolescents?
  10. New insights into the expression of androgen and estrogen receptors of the appendix testis in congenital cryptorchidism
  11. General properties of autoimmune thyroid diseases and associated morbidities
  12. Comparison of leptin levels in neonates born to mothers with high or low gestational weight gain
  13. Percentile values of serum zinc concentration and prevalence of its deficiency in Iranian children and adolescents: the CASPIAN-V study
  14. Nine-year overview of dyslipidemia management in children with heterozygous familial hypercholesterolemia: a university hospital outpatient lipid clinic project in Northwestern Greece
  15. Gesell Developmental Schedules scores and the relevant factors in children with Down syndrome
  16. Letters to the Editor
  17. Society for Pediatric Radiology (SPR) Child Abuse Committee response regarding Miller, Stolfi and Ayoub’s flawed theories about child abuse and metabolic bone disease
  18. Reply of Miller and Ayoub to Brown et al. Letter to the Editor
  19. Case Reports
  20. Identification of two novel variants in GAA underlying infantile-onset Pompe disease in two Pakistani families
  21. Hereditary vitamin D-resistant rickets: a report of four cases with two novel variants in the VDR gene and successful use of intermittent intravenous calcium via a peripheral route
  22. Variant analysis of HPD genes from two families showing elevated tyrosine upon newborn screening by tandem mass spectrometry (MS/MS)
  23. Challenges in the management of an ignored cause of hyperammonemic encephalopathy: pyruvate carboxylase deficiency
  24. Autoimmune polyglandular syndrome type II with co-manifestation of Addison’s and Graves’ disease in a 15-year-old boy: case report and literature review
Heruntergeladen am 30.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2019-0546/html
Button zum nach oben scrollen